February 8, 2023

Despite typically being well-tolerated, neither 150 mg nor 300 mg of risankizumab was beneficial in treating atopic dermatitis patients. Risankizumab is approved for treating moderate-to-severe psoriasis, active psoriatic arthritis, and moderate-to-severe active Crohn’s disease in adult patients. However, risankizumab is not effective for the treatment of atopic dermatitis, according to findings reported in a  multicenter,...

Mother-performed infant massage effectively promotes the remission of infantile eczema, reduces the chance of relapse, and alleviates the mother’s anxiety and depression. These findings are reported in a 5-month intervention study published in Frontiers in Public Health. It was found that infantile eczema severely affected the infants’ quality of life (QOL) and the mothers’ mental...